IMPAACT4TB Public Health Rationale Report

Click here to download PDF

CDC updated the recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) to treat latent TB infection, expanding the previous recommendation to include use of 3HP in children and adolescents 2–11 years old, use of 3HP in persons living with HIV/AIDS, and use of 3HP by self-administration.

Leave a Reply